IN BRIEF: PureTech Health reveals robust results from LYT-100 test
IN BRIEF: PureTech Health reveals robust results from LYT-100 test
Read moreIN BRIEF: PureTech Health reveals robust results from LYT-100 test
Read moreDIRECTOR DEALINGS: Micro Focus chair and new CFO buy shares
Read moreLONDON BROKER RATINGS: Deutsche Bank raises NatWest, cuts Barclays
Read moreTRADING UPDATES: Honye Financial loss widens; Highway loss narrows
Read moreTRADING UPDATES: FW Thorpe "up and down"; GB Group ties up US merger
Read moreIN BRIEF: PureTech Health reaffirms LYT-100 positive trial results
Read moreTRADING UPDATES: Permanent TSB sells loan portfolio; Dekel output up
Read more(Sharecast News) - Biotechnology company Puretech Health has received approximately $100.0m in cash from the sale of a portion of the group's shares in its founded entity Karuna Therapeutics.
Read moreTRADING UPDATES: Sealand's China progress; Altus finds gold
Read moreIN BRIEF: PureTech Health's Vedanta posts positive VE303 trial results
Read moreTRADING UPDATES: Inland gets Basildon permission; ICG assets grow
Read moreTRADING UPDATES: Fulham Shore mulls dividend; LoopUp swings to loss
Read morePureTech's Vor Biopharma granted FDA fast track for blood cancer drug
Read more(Sharecast News) - Clinical stage biotherapeutics firm PureTech Health on Friday said its founded entity, Vor Biopharma, had won US fast track approval for its leukaemia treatment.
Read more(Sharecast News) - Coats: Jefferies starts at buy with 97.0p target price.
Read more